VII

LIS Technologies Inc. Acquires 100% of CRISLA Inc., a USA Company That Holds a Patented Advanced Laser Enrichment Technology Viable for the Domestic Production of High-Assay Low Enriched Uranium (HALEU)

Retrieved on: 
Monday, August 14, 2023
Uranium, WPAFB, Atomic Energy Act of 1946, II, Congress, CO, Inflation, Acquisition, Patent, HEU, Berkeley, R, United States Patent and Trademark Office, Isotope, Nuclear engineering, GLE, University, MS, HALEU, Molecular laser isotope separation, VII, LIS, EUV, Entrepreneurship, Stellenbosch University, Intellectual property, Laser, USAF, Nuclear fuel, Eye, Nuclear energy, Physics, United States Congress, United, Void coefficient, UO2, SF6, LEU, DOE, Extreme ultraviolet, Laser isotope separation, Architecture, UF6, Inflation Reduction Act of 2022, MLIS, FTD, CO2, U3O8, Extracted, European Parliament Liaison Office with the US Congress, Rare-earth element, Uranium mining

A registered nuclear engineer in the State of California, he explored Molecular Laser Isotope Separation (MLIS) of gaseous UF6 and hexafluorides MoF6 and SF6.

Key Points: 
  • A registered nuclear engineer in the State of California, he explored Molecular Laser Isotope Separation (MLIS) of gaseous UF6 and hexafluorides MoF6 and SF6.
  • He has hands-on experience with nuclear reactors, uranium enrichment, nuclear rockets, and space satellite engineering.
  • He is an accomplished professional with 35 years of diverse technical & management experience in advanced laser & optical systems and applications.
  • Furthermore, the US Congress, through the Inflation Reduction Act, provided $700 million to support the development of a domestic supply chain for high-assay low-enriched uranium.

Banzai and 7GC & Co. Holdings Inc. Announce Amendment to Business Combination Agreement

Retrieved on: 
Monday, August 7, 2023
Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., Companies (1st Amendment) Act, 2015, Business, Business analyst, VII, Acquisition, SAN, Amendment, Security (finance), Hyro the Hero

SEATTLE and SAN FRANCISCO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Banzai International, Inc. (“Banzai” or the “Company”), a leading marketing technology company that provides data-driven marketing and sales solutions, and 7GC & Co. Holdings Inc. (NASDAQ: VII) (“VII” or “7GC”), a publicly-traded special purpose acquisition company, announced today that they have entered into an amendment (the "Amendment") to their previously disclosed definitive business combination agreement dated December 8, 2022 (the "Business Combination").

Key Points: 
  • SEATTLE and SAN FRANCISCO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Banzai International, Inc. (“Banzai” or the “Company”), a leading marketing technology company that provides data-driven marketing and sales solutions, and 7GC & Co. Holdings Inc. (NASDAQ: VII) (“VII” or “7GC”), a publicly-traded special purpose acquisition company, announced today that they have entered into an amendment (the "Amendment") to their previously disclosed definitive business combination agreement dated December 8, 2022 (the "Business Combination").
  • Banzai had previously agreed to acquire Hyros in a merger that was intended to close immediately prior to the closing of the Business Combination.
  • In connection with the Amendment, 7GC & Co. Holdings LLC (the “Sponsor”) agreed, contingent upon closing of the of the Business Combination, to forfeit all 7,350,000 of its private placement warrants acquired in connection with the 7GC initial public offering.
  • At the closing of the Business Combination, such forfeited private placement warrants will be transferred by the Sponsor to 7GC and cancelled in exchange for no consideration.

Top story - Changes in the European Commission 2023 - MEPs assess Iliana Ivanova as new Bulgarian commissioner

Retrieved on: 
Thursday, July 20, 2023
Treaty on European Union, Industry, Civil service commission, Education, Hearing, Culture, Commission, Research, Article, European Commission, Committee, Treaty, VII, McGuinness, Conference, Whaling, Explosive, Audit, Medical device, European

Parliament’s industry and culture committees will hold a hearing with Iliana Ivanova, who is the Bulgarian commissioner-designate.

Key Points: 
  • Parliament’s industry and culture committees will hold a hearing with Iliana Ivanova, who is the Bulgarian commissioner-designate.
  • Articles
    Articles
    Check out the official documents related to the evaluation of Iliana Ivanova as commissioner-designate for innovation, research, culture, education and youth.
  • Legal framework
    Legal framework
    The European Commission: article 17 of the Treaty on European Union
    Replacement of commissioners: article 246 of the Treaty on the Functioning of the European Union
    Election of the Commission: rule 125 of Parliament’s rules of procedure
    Guidelines for the approval of the Commission: annex VII to Parliament’s rules of procedure
    The European Commission 2019-2024
    The European Commission 2019-2024
    Articles about the election of the European Commission in 2019
    Articles about Parliament’s evaluation of Mairead McGuinness and Valdis Dombrovskis
    Responsible for the Hearing Associated to the Hearing Conference of Presidents Conference of Committee Chairs

Potash Fertilizers Market Size Expected To Reach $41 Billion By 2030 as Demand Explodes

Retrieved on: 
Wednesday, July 12, 2023
Well, PALM, Life, Fertilizer, NPK, FOB, Soil, MOP, NEWS, Management, Basse-Banio (department), Environment, News, NYSE, GSP, Executive, Technical report, NTR, OTCQB, FNM, Unit, Research, USD, Warrant, Intrepid Potash, VII, SEDAR, TSX, Growth, Security (finance), The Mosaic Company, Intrepid, NOT, Initiation, Federal Lands Jobs and Energy Security Act, HQ, Market research, Water, IPI, Family, Technical, Indian stock exchange, Food, Bed, MLP, Form 10-K, Nutrien, EDT, Plant, NEVER, Millennials, ANY, Horticulture, Annual report, DAP, Potassium, VI, Potash, Cryptocurrency, Phosphate

PALM BEACH, Fla., July 12, 2023 /PRNewswire/ -- Potash fertilizers help in the overall improvement of plant quality and also increases its shelf life. Potassium is a vital soil element and is one of the key members of the NPK fertilizer family. Natural potassium does not exist in the environment since it responds aggressively to water. Fertilizer potassium is at times called "potash", a term that originates from an early making procedure where potassium was filtered from ashes of woods and concentrated by dissipating the leachate in huge iron pots. A report from Verified Market Research projected that the Potash Fertilizers Market size is projected to reach USD 41.11 Billion by 2030, growing at a CAGR of 4.66% from 2023 to 2030. The report said: "In the production of food, potassium is eliminated from the soil in the crops that are harvested and should be replaced keeping in mind the end goal to keep up the crop growth in the future. It also helps to enhance crop yield, improvise taste, and further helps plants to resist diseases. Potash fertilizers are applied to various crop types such as cereals & grains, oilseeds & pulses, and fruits & vegetables. In terms of form, potash fertilizers are present in liquid & solid forms." Active companies in the markets this week include Millennial Potash Corp. (OTCQB: MLPNF) (TSX-V: MLP), The Mosaic Company (NYSE: MOS), Gensource Potash Corporation (OTCPK: AGCCF) (TSX-V: GSP), Intrepid Potash, Inc. (NYSE:IPI), Nutrien Ltd. (NYSE: NTR) (TSX: NTR).

Key Points: 
  • A report from Verified Market Research projected that the Potash Fertilizers Market size is projected to reach USD 41.11 Billion by 2030, growing at a CAGR of 4.66% from 2023 to 2030.
  • Potash fertilizers are applied to various crop types such as cereals & grains, oilseeds & pulses, and fruits & vegetables.
  • The potash fertilizer required depends on the type of crops developed because potassium take-up changes between crops and different soils.
  • The significant growth trend of the global population indicates an increasing demand for food, and in turn, would drive the demand for potash for the production of fertilizers."

Potash Fertilizers Market Size Expected To Reach $41 Billion By 2030 as Demand Explodes

Retrieved on: 
Wednesday, July 12, 2023
Well, PALM, Life, Fertilizer, NPK, FOB, Soil, MOP, NEWS, Management, Basse-Banio (department), Environment, News, NYSE, GSP, Executive, Technical report, NTR, OTCQB, FNM, Unit, Research, USD, Warrant, Intrepid Potash, VII, SEDAR, TSX, Growth, Security (finance), The Mosaic Company, Intrepid, NOT, Initiation, Federal Lands Jobs and Energy Security Act, HQ, Market research, Water, IPI, Family, Technical, Indian stock exchange, Food, Bed, MLP, Form 10-K, Nutrien, EDT, Plant, NEVER, Millennials, ANY, Horticulture, Annual report, DAP, Potassium, VI, Potash, Cryptocurrency, Phosphate

 PALM BEACH, Fla., July 12, 2023 /PRNewswire/ -- Potash fertilizers help in the overall improvement of plant quality and also increases its shelf life. Potassium is a vital soil element and is one of the key members of the NPK fertilizer family. Natural potassium does not exist in the environment since it responds aggressively to water. Fertilizer potassium is at times called "potash", a term that originates from an early making procedure where potassium was filtered from ashes of woods and concentrated by dissipating the leachate in huge iron pots. A report from Verified Market Research projected that the Potash Fertilizers Market size is projected to reach USD 41.11 Billion by 2030, growing at a CAGR of 4.66% from 2023 to 2030. The report said: "In the production of food, potassium is eliminated from the soil in the crops that are harvested and should be replaced keeping in mind the end goal to keep up the crop growth in the future. It also helps to enhance crop yield, improvise taste, and further helps plants to resist diseases. Potash fertilizers are applied to various crop types such as cereals & grains, oilseeds & pulses, and fruits & vegetables. In terms of form, potash fertilizers are present in liquid & solid forms." Active companies in the markets this week include Millennial Potash Corp. (OTCQB: MLPNF) (TSX-V: MLP), The Mosaic Company (NYSE: MOS), Gensource Potash Corporation (OTCPK: AGCCF) (TSX-V: GSP), Intrepid Potash, Inc. (NYSE:IPI), Nutrien Ltd. (NYSE: NTR) (TSX: NTR).

Key Points: 
  • A report from Verified Market Research projected that the Potash Fertilizers Market size is projected to reach USD 41.11 Billion by 2030, growing at a CAGR of 4.66% from 2023 to 2030.
  • Potash fertilizers are applied to various crop types such as cereals & grains, oilseeds & pulses, and fruits & vegetables.
  • The potash fertilizer required depends on the type of crops developed because potassium take-up changes between crops and different soils.
  • The significant growth trend of the global population indicates an increasing demand for food, and in turn, would drive the demand for potash for the production of fertilizers."

Hemab Therapeutics Presents New Preclinical Research Demonstrating Effects of Its Bispecific Antibody HMB-001 in Factor VII Deficiency

Retrieved on: 
Saturday, June 24, 2023
Database, Arm, Bleeding, Therapy, Coagulation, Woman, Skull, Coagulopathy, RNA, Doctor of Philosophy, ISTH, Small RNA, Congress, VII, Animal, MD, Thrombosis, International Society on Thrombosis and Haemostasis, European Association of Urology, Phenotype, International Society, Dietary supplement, Glycoprotein IIb/IIIa

COPENHAGEN, Denmark and BOSTON, June 24, 2023 /PRNewswire/ -- Hemab Therapeutics, a clinical-stage biotechnology company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, announced results today from preclinical research of HMB-001 in models of factor VII (FVII) deficiency at the International Society on Thrombosis and Haemostasis (ISTH) 2023 Congress in Montreal.

Key Points: 
  • "The new preclinical data presented today show HMB-001 successfully targeted and accumulated endogenous FVIIa to levels that would be expected to provide clinical benefit in FVII deficiency, supporting the potential for HMB-001 in an additional underserved bleeding disorder."
  • FVII is a protein necessary in the formation of hemostatic plugs to control bleeding.
  • The total accumulation of FVIIa observed with HMB-001 was comparable to the normal range seen in healthy animals.
  • These initial results suggest HMB-001 may have potential application as a treatment for FVII deficiency.

7GC & Co. Holdings Inc. Announces Postponement of its Special Meeting of Stockholders and Extension of Redemption Date

Retrieved on: 
Thursday, June 15, 2023
Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., Shareholder, Date, Internet, Extension, The Meeting, VII, SAN, Proxy, Holding company

The record date for the Meeting to vote on the Extension remains the close of business on May 16, 2023 (the “Record Date”).

Key Points: 
  • The record date for the Meeting to vote on the Extension remains the close of business on May 16, 2023 (the “Record Date”).
  • Stockholders who have previously submitted their proxy or otherwise voted and who do not want to change their vote need not take any action.
  • Stockholders as of the Record Date can vote, even if they have subsequently sold their shares.
  • Stockholders who wish to withdraw their previously submitted redemption request may do so prior to the rescheduled Meeting by requesting that the transfer agent return such shares.

Allianz Trade 2023 Global Survey

Retrieved on: 
Thursday, June 1, 2023
Insurance, Finance, Banking, Professional Services, Supply Chain Management, Logistics, Transport, Retail, Carbon, Pressure, XI, Economy, Economic Research Institute for ASEAN and East Asia, Risk management, IX, Public policy, Cost accounting, Carbon Border Adjustment Mechanism, Virginia Tech Corporate Research Center, Small and medium-sized enterprises, VII, Allianz, COVID-19, Small, VIII, Corporation, Euler Hermes, Disease, ESG, Mortality, Health, Environment, III, AA, VI, Renewable energy, Bank

Today, Allianz Trade releases the second edition of its Global Survey.

Key Points: 
  • Today, Allianz Trade releases the second edition of its Global Survey.
  • This echoes the less favourable environment for global trade in 2023: Allianz Trade expects global trade to grow slowly in terms of volume (+0.7% vs. +3.8% in 2022) and to decline in terms of value (-0.1% vs. +9.7% in 2022).
  • This growing interest could also unlock trade financing for Small and Medium Enterprises that were previously shying away from global trade,” states Ano Kuhanathan, Head of Corporate Research at Allianz Trade.
  • We predict trade and credit risk today, so companies can have confidence in tomorrow
    Allianz Trade is the global leader in trade credit insurance and a recognized specialist in the areas of surety, collections, structured trade credit and political risk.

FDA Approves Groundbreaking New Product Utilizing Berkshire Sterile Excipient Gel to Treat 'Butterfly Children'

Retrieved on: 
Thursday, May 25, 2023
COL7A1, DEB, Dermis, Tears, Epidermis, BSM, Concha bullosa, VII, CGMP, Patient, MA, Quality assurance, Blister, Paratriathlon, FDA, Trauma, Skin, Disease, Vaccine

BSM supplies an excipient gel, a key component of this new and innovative therapy.

Key Points: 
  • BSM supplies an excipient gel, a key component of this new and innovative therapy.
  • VYJUVEK is the first and only FDA approved treatment for DEB and is designed to address the underlying genetic cause of the disease.
  • Berkshire Sterile Manufacturing manufactures an excipient gel that forms a component of the product, which is applied topically to open wounds on the skin.
  • “We are motivated to deliver these treatments to our clients and their patients, and that means meeting the most stringent quality standards throughout the manufacturing process.”

Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™

Retrieved on: 
Tuesday, May 23, 2023
COL7A1, KRYS, DEB, Pharmacy, Medicine, History, Concha bullosa, VII, OPCH, Patient, FDA, Syringe, Pharmaceutical industry, Nursing, Amedisys

BANNOCKBURN, Ill., May 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH) today announced that it was selected by Krystal Biotech, Inc. (“Krystal Biotech”) (Nasdaq: KRYS) as part of a limited distribution specialty pharmacy network for VYJUVEK™. VYJUVEK was approved by the U.S. Food & Drug Administration (FDA) on May 19, 2023 for the treatment of patients with dystrophic epidermolysis bullosa (DEB).

Key Points: 
  • BANNOCKBURN, Ill., May 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH) today announced that it was selected by Krystal Biotech, Inc. (“Krystal Biotech”) (Nasdaq: KRYS) as part of a limited distribution specialty pharmacy network for VYJUVEK™.
  • VYJUVEK was approved by the U.S. Food & Drug Administration (FDA) on May 19, 2023 for the treatment of patients with dystrophic epidermolysis bullosa (DEB).
  • Through the national footprint of over 95 specialty pharmacies strategically located across the U.S., Option Care Health will serve as the only specialty pharmacy provider for mixing and delivering prepared VYJUVEK gel administration syringes to professional healthcare and home settings.
  • Option Care Health will collaborate with Amedisys, Inc. on this effort, including for Amedisys nurses to deliver and administer VYJUVEK to patients.